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Abstract 
Intramedullary spinal cord (SC) tumors 
are relatively rare tumors, accounting for 
only 2% to 4% ofcentral nervous 
systemtumors.These 
tumorsaregenerallyslow-growing 
tumorsthatcouldbenefitfromsurgical 
removal. A pre-surgery identification of the 
tumor histology might improve the surgical 
management of the tumor and also properly 
predict the functional outcome after 
surgery. The neuroimaging techniques, 
provide crucial information about tumors 
anatomy. By adding the medical history of 
the present illness and detailed clinical 
examination, the imaging data might 
however be extremely helpful in the 
prediction of tumor histology. This will 
allow anappropriate surgical 
managementofthese lesions and provide 
pertinent predictors of the functional 
outcome post-surgery. Therefore, the 
surgeon can set the patient’s expectations at 
a realistic level. 
The present studyis a prospective 
study,aiming to use combined clinical and 
imaging data to predictthe intramedullary 
SC tumor histology. The primary 
objectiveis to identify the pathognomonic 
clinical and imaging pattern for eachtumor 
type. 
The study was conducted in the 
Neurosurgery Clinic Emergency Clinic 
Hospital Bagdasar-Arseni between 2006 
and 2009. A total of 36 patients (19 
females/17 males) participated. All patients 
were evaluated for motor, sensory, 
sphincter, walking and balance functions. 
MRI assessment was used to determine the 
presence of an intramedullary SC tumor as 
well as its characteristics. 
All histological types have a long history 
of symptoms, which depends of locations in 
longitudinal plane. All intramedullary 
tumors presented spinal cord dilatation on 
MRI. We confined the clinico-radiological 
characteristics of each histological type, 
strongly correlated with histopathological 
analysis, extensively presented in the paper.   
By combining a careful medical history, 
clinical examination and MRI data, we 
could predict with a reasonable accuracy in 
preoperative stage the histological type of an 
intramedullary tumor.  
Keywords:  astrocytoma, ependymoma,  
intramedullary tumor, spinal cord tumor 
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Introduction 
Although the intramedullary spinal cord 
(SC) tumors are relatively rare tumors, 
accounting for only 2% to 8.5% of central 
nervous system tumors, thousands of 
patients are annually affected (Fehlings and 
Craciunas 2010; Craciunas 2010). 
Hemangioblastoma and glial tumors 
represent more than 90% of intramedullary 
spinal cord tumors, with ependymomas 
accounting for 35% to 40% of these tumors. 
These entities are generally slow-growing 
tumors that could benefit from surgical 
removal. However, their histology, e.g., 
benign or malignant, has a particular 
clinical significance. Further, this 
significance depends on the tumor’s 
location.  For instance, a high cervical area 
WHO grade I tumor potentially has a worse 
prognosis compared to a thoraco-lumbar 
WHO grade III tumor due to high 
functional and surgical risks associated to 
the cervical location. Therefore, a pre-
surgery identification of the tumor 
histology might improve the surgical 
management of the tumor and also properly 
predict the functional outcome after 
surgery.  
The neuroimaging techniques, e.g., 
magnetic resonance imaging (MRI), which 
have undergone spectacular development in 
recent years, provide crucial information 
about tumors anatomy. By adding the 
medical history of the present illness and 
detailed clinical examination, the imaging 
data might however be extremely helpful in 
the prediction of tumor histology. This will 
allow an appropriate surgical management 
of these lesions and provide pertinent 
predictors of the functional outcome post-
surgery. Therefore, the surgeon can set the 
patient’s expectations at a realistic level. 
The present study is a prospective study, 
aiming to use combined clinical and 
imaging data to predict the intramedullary 
SC tumor histology. The primary objective 
is to identify the pathognomonic clinical 
and imaging pattern for each tumor type. 
Specifically, we analyzed: (i) demographic 
data, e.g., age, gender, (ii) history of the 
present illness, e.g., the duration of the 
symptoms until diagnosis, (iii) clinical 
symptoms, such as the type of neurological 
dysfunction: motor, sensory, sphincter 
function, gait, and/or balance; and the 
degree of functional impairment, as 
evaluated by McCormick and ASIA 
classification, and (iv) imaging data: lesion 
location, lesion size on the sagittal plan, e.g. 
number of vertebral segments affected, cyst 
formation (intratumoral, polar, bulbar), 
syringomyelia,  intensity of T1-, T2-, or 
T1-Gd-weighted signal, filling with 
contrast, and other imaging features, such 
as edema, infiltrative appearance.  
Material and methods  
Participants  
The study was conducted in the 
Neurosurgery Clinic Emergency Clinic 
Hospital Bagdasar-Arseni between 2006 
and 2009.  
 A total of 36 patients (19 females/17 
males) participated. Patients were included 
whether (i) they were diagnosed with 
intramedullary SC tumor, (ii) aged between 
18 and 75 years, and (iii) able to perform a 
MRI examination. Explicit exclusion 
criteria were: (i) previous surgery, chemo-, 
or radio-therapy for an intramedullary 
tumor, (ii) major cognitive dysfunction, 
limiting the ability to provide a detailed 
history, (iii) pre-existing neurological 
disorders, (iv) history of SC injury, (v) 
presence of systemic diseases, such as liver 
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failure, metabolic disorders, uremia, 
transplantation, uncontrolled diabetes, (vi) 
substance or alcohol abuse, and (vii) 
treatment with neuroleptics or 
antiepileptics. 
Medical history was focused on the type 
of the symptoms onset (acute / subacute / 
insidious), the duration between symptoms 
onset and diagnosis, and intensity of the 
symptoms (as evaluated by a self-reported 
questionnaires). 
Clinical Measurements  
Immediately after the diagnosis of 
intramedullary SC tumor, all patients 
completed a neurological examination 
comprised of motor, sensory, sphincter, 
walking and balance functions. Functional 
assessment was completed by using 
McCormick classification (see Table 1). 
 
TABLE 1 
McCormick grades 
Grade Description 
I Neurologically normal, mild focal to 
no functional deficits of the involved 
limb, mild spasticity or reflex 
abnormality, normal gait 
II Mild to moderate limb sensorimotor 
deficit, mild to moderate gait 
difficulty, severe pain or dysesthetic 
syndrome impairing the quality of life. 
However, the patient function and 
walk independently 
III More severe neurological deficit, with 
the patient requiring a cane or brace to 
walk, or with significant bilateral 
upper extremity impairment; the 
patient may or may not be able to 
function independently 
IV Severe deficit, with the patient 
requiring a wheelchair, cane or brace, 
with bilateral upper extremity 
impairment; the patient is usually 
dependent 
 
 
MRI measurements 
MRI assessments were performed for 
diagnosis. Basically, the imaging assessment 
was used to determine the presence of an 
intramedullary SC tumor as well as its 
characteristics, e.g., extent, location, 
presence or not of cysts and/or fluid cavity, 
contrast loading, and presence of the 
cleavage plane between the tumor and the 
surrounding tissue.   
Histological analysis 
Conventional histological analysis was 
sufficient to diagnose in most cases. 
However, for an accurate diagnosis, 
immunochemistry was added in seven cases 
and electron microscopy and 
molecular/genetic tests in one case.  
Statistical analysis 
Statistical analysis was focused on one 
outcome (tumor histology) and five 
variables: demographic, neurological and 
imaging data, type of symptoms onset and 
symptoms duration. Spearman correlations 
were used to analyze relationships between 
outcome and variables. Significant 
correlations were considered at p<0.05 
(SPSS 18.0, SPSS Inc. Chicago, IL). 
Results  
Demographic characteristics 
In our sample, we found two peaks in 
age distribution, at 20-29 yrs and 40-59 yrs, 
with a mean age of diagnosis of 40.5 yrs 
(range between 18 and 72). We focus the 
present study on the adult patients (aged 
more than 18 yrs), although the frequency 
of intramedullary tumors is almost equal or 
even higher in pediatric than in adult 
population (Kothbauer 2007; Gepp Rde et 
al. 2010; Adam et al. 2010; Harrop et al. 
2009; McGirt, Chaichana, Atiba, Attenello, 
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Yao, et al. 2008). With regard to the gender, 
we did not find any gender dominance. 
42% of our patients have been diagnosed 
with ependymoma and 22% with 
astrocytoma (see Table 2). However, the 
high incidence of ependymoma in our 
series (42%) is due to the exclusion of 
pediatric patients from our group, where 
the astrocytoma is the most frequent 
intramedullary tumor. The rest of 36% 
patients presented cavernoma, hamartoma, 
oligodendroglioma, ganglioglioma, 
hemangioblastoma, and metastasis (see 
Table 2).  
TABLE 2 
Distribution by tumor histology 
Tumor histology  # cases  
Ependymoma 15 
Astrocytoma  8 
Cavernoma 4 
Hamartoma 3 
Ganglioglioma 2 
Hemangioblastoma 2 
Oligodendroglioma 1 
Metastasis 1 
 
In our patients, 86% of tumors were 
classified WHO grade I and II, 11% grade 
III, and 3% grade IV. Further, the tumors 
were located particularly at the thoracic 
level, followed by the cervical level. With 
regard to tumor length, the majority of 
tumors extended over one to two vertebral 
levels.   
Clinical results 
Intramedullary SC tumors produced a 
clinical picture consistent with their 
location. Local pain (spinal) is a common 
occurrence. 
In our patients, the first symptom was 
paresthesia in 50%, pain in 36%, motor 
deficit in 11%, and proprioception 
disturbance in 3% (see Figure 1). 
 
 
Figure 1 Intramedullary Tumors – First Symptom 
 
 
Figure 2 Intramedullary Tumors – Signs and symptoms on admission 
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Regarding the interval between 
symptoms onset and diagnosis, the average 
time was 20 months, ranging between 0.5 
and 240 months. The case with the rapid 
presentation at the hospital (2 weeks) was 
due to a progressive cauda equina syndrome 
generated by a metastatic lung 
adenocarcinoma. In contrast, the case with 
the longest interval between symptoms 
onset and diagnosis (240 months) was a T8-
T9 thoracic ependymoma.  
On admission (see Figure 2,), the 
sensitive (both objective and subjective) and 
motor deficits dominated the clinical 
features in our patients. However, motor 
deficits were mostly mild to medium (ASIA 
C in 6 cases, D in 23, and E in 7).  
Sphincter disturbances occurred in 53% 
of cases. In more than half of them were 
mild disturbances, such as uncontrolled 
emission of urine in small quantities or 
mild urinary retention. 
Thirteen patients presented walking 
impairment (see Figure 2). Of these, nine 
patients (70%) were non-ambulatory.  
As functional impairment, 39% of 
patients were McCormick I, 39% 
McCormick II, and 22% McCormick III, 
and no McCormick IV.  
MRI findings 
Spinal cord expansion at tumor’s level 
was presented in all cases.  Although the 
"cap sign" is not pathognomonic, we 
noticed this feature in 87% of our cases 
with ependymoma and in 50% of those 
with hemangioblastoma. However, this 
feature was absent in our patients with 
astrocytoma. (See Figure 3) 
Small areas of hypointensity on T1- and 
T2-weighted images are reflective for 
calcifications. We met this feature in only 3% 
of our cases (dermoid cyst). (See Figure 4) 
Intratumoral hypointensities could be 
interpreted as abnormal vascular flow, 
corresponding to intratumoral vessels. We 
noticed these characteristics especially in 
both cases with hemangioblastoma. 
The tumor cysts were present in 15 
patients (42%). All these patients were 
diagnosed with glial tumors (astrocytoma, 
ependymoma, ganglioglioma or 
oligodendroglioma). Polar cysts were 
present in eight cases (22%), of which five 
were ependymoma. Further, both cases 
with ganglioglioma also showed polar cysts. 
In the present study, none of our patients 
showed bulbar cysts. 
Syringomyelia was present in 39% of 
cases. Three out of the four cases with 
hamartoma presented syringomyelia.  
In 20 out of 35 cases, we found 
peritumoral edema, more notable in 
patients with hemangioblastoma and 
ependymoma.  
In most tumors (33 out of 36 cases), we 
found varied degrees of contrast 
enhancement. However, in three cases 
(pilocytic astrocytoma, subependymoma 
and cavernous hemangioma), we found no 
contrast enhancement.  
Discussion 
Clinical results 
Local pain is a common occurrence in 
intramedulary tumors. This was the most 
frequent symptom in our series. Unlike 
extramedullary tumors, pain is rarely nerve 
root type (Harrop et al. 2009; Garces-
Ambrossi et al. 2009; Fehlings and Mercier 
2009; Yang, Yang, and Hong 2009). 
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Figure 3 Ependymoma T9-T10 - Sagittal T2(a), T1(b), STIR(c), T1-Gd(d), Axial T2(e), T1-Gd(f) – to note 
specific aspects: hyperdense in T2, hypodense in T1, contrast enhancing mass central located in spinal cord 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 Dermoid cyst T12-L1 – axial CT(a), sagittal CT(b), sagittal T2(c), sagittal T1-Gd(d), axial T1(e,f), 
intraoperative ultrasonography (g,h) -  inhomogeneous aspect, calcifications present. (Thanks to Dr. Michael 
Fehlings – University of Toronto, for allowing us to present the case) 
 
Since the intramedullary tumors are 
often developed in the central canal region, 
there is frequently noticed an early 
involvement of spino-thalamic tracts, with 
the sparing of the posterior columns (Jallo, 
Freed, and Epstein 2003; Bowers and 
Weprin 2003; Wang and Liu 1999; Koerbel 
et al. 2002; Maira et al. 2001; Clemenceau 
and Lopez 2001). Subsequently, these 
patients develop burning pain involving 
a f d c b 
e 
a b c d 
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large areas of the body. A typical clinical 
picture is a segmental, dissociated-type 
sensibility impairment, affecting the 
sensitivity for pain and temperature (Raco 
et al. 2005; Shrivastava et al. 2005; Brotchi 
2004; Antoniadis et al. 2005). Pain is 
typically funicular-type, and can be 
triggered by a variety of stimuli, including 
motion and skin irritation. Lhermitte sign is 
also frequently seen in these patients (Yang, 
Yang, and Hong 2009; Sun et al. 2009; 
Manzano et al. 2008; Berhouma et al. 2009; 
Taricco et al. 2008; McGirt, Chaichana, 
Atiba, Attenello, Yao, et al. 2008; Nakamura 
et al. 2008; McGirt, Chaichana, Atiba, 
Attenello, Woodworth, et al. 2008). As these 
tumors grow in size, the pyramidal tracts 
might be affected. Consequently, motor 
deficits and spasticity may occur in the 
proximal and then distal affected limb. This 
is a clinical characteristic of intramedullary 
tumors (Gepp Rde et al. 2010; Sun et al. 
2010; Adam et al. 2010; Garces-Ambrossi et 
al. 2009; Fehlings and Mercier 2009; 
Harrop et al. 2009; Yang, Yang, and Hong 
2009). Intramedullary tumors located in 
conus and cauda equina often present as 
early symptom the genital and sphincter 
dysfunctions (Gepp Rde et al. 2010; Sun et 
al. 2010; Adam et al. 2010; Garces-
Ambrossi et al. 2009; Fehlings and Mercier 
2009; Harrop et al. 2009; Yang, Yang, and 
Hong 2009). In addition, these entities can 
exhibit signs and symptoms of autonomic 
nervous impairment in conjunction with 
motor and sensitive deficits. If the lateral 
horn is involved, Horner's syndrome or 
thermoregulatory and vasomotor 
dysfunction can occur (Gepp Rde et al. 
2010; Sun et al. 2010; Adam et al. 2010; 
Garces-Ambrossi et al. 2009; Fehlings and 
Mercier 2009; Harrop et al. 2009; Yang, 
Yang, and Hong 2009; Sun et al. 2009; 
Manzano et al. 2008; Berhouma et al. 2009; 
Taricco et al. 2008; McGirt, Chaichana, 
Atiba, Attenello, Yao, et al. 2008; Nakamura 
et al. 2008; McGirt, Chaichana, Atiba, 
Attenello, Woodworth, et al. 2008; Sala et 
al. 2007). 
The clinical course of these tumors is 
most often an insidious process. In our 
patients, only one case presented 
neurological deterioration over 2 weeks, the 
rest of them having a slow progression of 
symptoms. Patients tend to adapt and 
compensate the symptoms and as a result 
they are diagnosed at a relatively advanced 
stage. However, an acute neurological 
deterioration can be detected when 
intratumoral hemorrhage occurs (Gepp 
Rde et al. 2010; Sun et al. 2010; Adam et al. 
2010; Garces-Ambrossi et al. 2009; Fehlings 
and Mercier 2009; Harrop et al. 2009; Yang, 
Yang, and Hong 2009; Sun et al. 2009; 
Manzano et al. 2008; Berhouma et al. 2009; 
Taricco et al. 2008; McGirt, Chaichana, 
Atiba, Attenello, Yao, et al. 2008; Nakamura 
et al. 2008; McGirt, Chaichana, Atiba, 
Attenello, Woodworth, et al. 2008; Sala et 
al. 2007).  
Therefore, the typical history of 
symptoms was a gradual and slow 
progression, without remission of 
symptoms. This is an important finding 
that can be used to differentiate between 
the intramedullary tumors and 
inflammatory demyelinating syndromes. 
The latter rapidly develop significant 
deficits in days or weeks and then show 
some variability in terms of intensity and 
location of symptoms. In contrast,  an acute 
onset of symptoms in intramedullary 
tumors occurs only in rare cases, usually 
associated with intratumoral hemorrhage or 
tumors with high malignancy. (see Table 3) 
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MRI findings 
There are many radiological techniques 
available for the diagnosis of spinal 
pathology such as: standard radiological 
views, computed tomography (CT), 
myelography, spinal arteriography and 
MRI. Traditional imaging modalities 
(conventional radiological views and CT) 
often fail to indicate the true extension of 
intramedullary neoplasms, being able to 
detect these entities only when the massive 
tumor growth occurred. Myelography, 
acquired both by conventional radiology or 
CT, shows an intramedullary mass blocking 
(completely or partially) the migration of 
the contrast agent into the intrathecal space.  
MRI provides a non-invasive method to 
identify abnormalities associated with these 
tumors such as cystic formations, 
syringo/hydromyelia, bleeding and swelling 
had become a routine in the evaluation of 
intramedullary spinal masses. In our series, 
all patients underwent MRI for diagnosis 
and preoperative management. We used 
other imaging techniques only for 
confining the anatomy/location of the 
lesion with supplemental accuracy.  
Currently, MRI is the modality of 
choice for the evaluation of intraspinal 
masses. MRI evaluation should include T1, 
T2 and T1-Gd weighted sequences, in both 
sagittal and axial planes. Contrast agent 
enhancement is particularly important in 
determining the solid portion of 
intramedullary neoplasms and cysts 
associated with identification and other 
items that can often change the differential 
diagnosis (Sze et al. 1990; Adam et al. 2010; 
Garces-Ambrossi et al. 2009; Fehlings and 
Mercier 2009; Harrop et al. 2009).  
Although MRI is a very powerful 
diagnostic tool, its ability to predict tumor 
histology was considered limited in the 
past. For instance, in a series of 171 patients 
with intramedullary tumors (Brotchi et al. 
1991), MRI aspects were correlated with 
the tumor histology in only 70% of cases. In 
particular, the MRI differentiation between 
astrocytoma and ependymoma was difficult.  
There are three major MRI 
characteristics for the intramedullary 
tumors.  First, the expansion of the SC 
(Takemoto et al. 1988; Adam et al. 2010; 
Garces-Ambrossi et al. 2009; Fehlings and 
Mercier 2009; Harrop et al. 2009; Yang, 
Yang, and Hong 2009; Sun et al. 2009; 
Manzano et al. 2008; Berhouma et al. 2009) 
can be used to differentiate between 
neoplastic and non-neoplastic entities. 
Specifically, an absence of SC expansion 
suggests rather a non-neoplastic (e.g., 
demyelinating disease, sarcoidosis, amyloid 
angiopatie, pseudotumors, arteriovenous 
fistulae, spinal cord infarction, cystic 
myelomalacia) than neoplastic etiology (Lee 
et al. 1996; Andrews et al. 1988; Dillon et al. 
1989; Adam et al. 2010; Garces-Ambrossi et 
al. 2009; Fehlings and Mercier 2009; 
Harrop et al. 2009; Yang, Yang, and Hong 
2009; Sun et al. 2009; Manzano et al. 2008; 
Berhouma et al. 2009). Obviously, this 
differentiation is critical for surgical 
management. Explicitly, if there is a high 
probability for a lesion to be a neoplasm, 
extensive tumor resection should be 
recommended. In contrast, if a lesion is 
likely a non-neoplasm entity, a biopsy 
rather than a surgical approach would be 
indicated. Subsequently, these patients 
avoid the risks of aggressive surgery with 
significantly lower postoperative morbidity 
(Lee et al. 1996; Adam et al. 2010; Garces-
Ambrossi et al. 2009; Fehlings and Mercier 
2009; Harrop et al. 2009; Yang, Yang, and 
Hong 2009; Sun et al. 2009; Manzano et al. 
2008; Berhouma et al. 2009). For example, 
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in a series of 212 patients with 
intramedullary masses, nine (4%) had non-
neoplastic lesions confirmed on the MRI 
images, e.g., no SC expansion(Lee et al. 
1996). Second, most intramedullary spinal 
neoplasms show contrast enhancement 
(Parizel et al. 1989; Dillon et al. 1989; Sze et 
al. 1988; Goy et al. 1986; Bydder et al. 1985; 
Froment 1996; Adam et al. 2010; Garces-
Ambrossi et al. 2009; Fehlings and Mercier 
2009; Harrop et al. 2009; Yang, Yang, and 
Hong 2009; Sun et al. 2009; Manzano et al. 
2008; Berhouma et al. 2009). Therefore, in 
evaluating a patient suspected to have such 
pathology, it is mandatory to obtain 
contrast-enhanced images in at least two 
plans. This is essential for both diagnosis 
and treatment approaches. However, the 
absence of contrast enhancement does not 
exclude a neoplasm (Froment 1996) and 
caution is recommended in the 
interpretation of this MRI characteristic. 
Finally, cystic formations are elements 
relatively common for the intramedullary 
tumors. We found cystic entities in almost 
half of cases, especially in glial tumors. 
There are two basic types of cysts, tumoral 
and non-tumoral. Cysts located at the poles 
of solid portion of tumor are usually simple 
reactive dilations of the central canal 
(syringomyelia) or they originate in the 
fluid produced by the neoplasm (Epstein 
and Epstein 1982; Harrop et al. 2009; Yang, 
Yang, and Hong 2009; Sun et al. 2009; 
Manzano et al. 2008; Berhouma et al. 
2009). Approximately 60% of all 
intramedullary tumors show polar cysts. 
These cystic cavities can be spontaneously 
decompressed following tumor resection or 
can be aspirated by the surgeon during 
resection(Epstein, Farmer, and Schneider 
1991; Harrop et al. 2009; Yang, Yang, and 
Hong 2009; Sun et al. 2009; Manzano et al. 
2008; Berhouma et al. 2009). These 
formations are part of the cystic tumor, and 
therefore will not load contrast (Epstein, 
Farmer, and Schneider 1991). In contrast, 
tumor cysts are contained within the tumor 
and often shows peripheral contrast 
enhancement (Froment 1996; Waldron and 
Cha 2006). These entities tend to be 
observed more frequently in astrocytoma 
than in ependymoma (Epstein, Farmer, and 
Schneider 1991; Waldron and Cha 2006). 
Identifying the contrast-enhancing solid 
portion of tumor (including the tumor cyst) 
is vital because current neurosurgical 
techniques allow laminectomy/laminotomy 
limited only to these areas, with consequent 
decreased surgical morbidity. 
Intramedullary tumor MRI characteristics  
Topography: The standard radiological 
views may be useful in precisely 
determining the level of spinal lesion, 
especially if vertebral anomalies are present. 
If this is not possible, imaging studies 
should include anatomical structures that 
allow the identification of the level. For 
instance, using a wide field imaging (e.g. 
antenna array of 512) allows the location of 
the two poles of the tumor by counting the 
vertebrae from the sacral-iliac joint or 
odontoid process. A central location within 
the spinal canal favors the diagnosis of 
ependymoma, while eccentric location 
suggests a diagnosis of astrocytoma, 
hemangioblastoma or lipoma (Adam et al. 
2010; Harrop et al. 2009; Manzano et al. 
2008; Waldron and Cha 2006; Bowers and 
Weprin 2003; Hoshimaru 2001). Our 
results were consistent with those reported 
in the literature.  
Signal characteristics: MRI allows 
differentiating solid and cystic portions of 
tumors and demonstrates the presence or 
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absence of swelling and signal changes 
following contrast loading.  
The solid portions of most 
intramedullary tumors are hypointense or 
isointense on T1-weigthed images and 
isointense or hyperintense on T2-weigthed 
image. These signal abnormalities are 
generally well defined and can have either 
homogeneous or heterogeneous 
appearance.  For example, a clear 
hyperintensity on T1-weighted image 
suggests the presence of sub-acute blood 
(from 3-5 days to a month after bleeding) 
while a hypointensity on T2-weighted 
images with margins more or less defined 
on T1 reflects hemosiderin, characteristic 
feature of chronic bleeding (months to 
years after bleeding). Another example is 
the "cap sign", a hypointensity on both poles 
of the solid tumor that was histologically 
and intra-operatively correlated with areas 
of chronic hemorrhage. In our sample, this 
feature were consistently present in 
ependymoma cases. 
Cystic formations represent a common 
feature associated with solid portion of  
intramedullary tumor and several types of 
cysts have been reported (Adam et al. 2010; 
Harrop et al. 2009; Manzano et al. 2008; 
Waldron and Cha 2006; Bowers and 
Weprin 2003; Hoshimaru 2001). The 
majority of our patients presented cysts. 
Intratumoral cysts usually have a different 
signal from that of CSF due to the high-
protein or blood content, e.g., low signal on 
T1 and high signal on T2-weighed images. 
They have a well-defined contour and their 
walls load the contrast substance after 
injection (Adam et al. 2010; Harrop et al. 
2009; Manzano et al. 2008; Waldron and 
Cha 2006; Bowers and Weprin 2003; 
Hoshimaru 2001). Polar cysts can be 
present at both upper and lower poles of 
the tumor, with a signal similar with that 
obtained from CSF, e.g., low T1 signal and 
high T2 signal. However, there are some 
varieties of the signal acquired from these 
cysts. Further, these cysts are characterized 
by: (i) appearance to be under tension, (ii) 
often round shape, and (iii) walls that do 
not load the contrast substance. 
Syringomyelia cavities, associated with 
intramedullary tumors, have their terminal 
portions often filiform and satellite cysts 
may coexist even if the communication 
with the syringomyelic cavity is not always 
visible. These cysts also appear to be under 
tension, but their walls do not have specific 
characteristics and do not exhibit contrast 
enhancement. Finally, bulbar cysts have a 
convex appearance and a signal similar to 
CSF. They are usually located under the 
floor of the fourth ventricle, far from the 
tumor and communicate with the subjacent 
syringomyelic cavity. After tumor removal 
and the subsequent opening of the cyst cavity 
and drainage of the syringomyelic cavity, 
these cysts gradually regress and disappear in 
a several months (Adam et al. 2010; Harrop et 
al. 2009; Manzano et al. 2008; Waldron and 
Cha 2006; Bowers and Weprin 2003; 
Hoshimaru 2001). (See Table 4) 
Peritumoral edema is another feature of 
the intramedullary tumors that can be 
identified on MRI images, such as a 
hyperintensity on T2-weigthed images. 
Peritumoral edema can be extensive, 
especially in hemangioblastoma, and 
disappears after tumor resection (Adam et 
al. 2010; Harrop et al. 2009; Manzano et al. 
2008; Waldron and Cha 2006; Bowers and 
Weprin 2003; Hoshimaru 2001). (See Table 
4). 
The capability of these lesions to uptake 
or not the contrast substance is essential for 
diagnosis. For instance, contrast 
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enhancement of the cystic walls suggests a 
neoplastic nature. For the solid portion of 
the tumors, the regular appearance is 
moderately to very intense uptake of the 
contrast substance (particularly in 
hemangioblastoma) (Waldron and Cha 
2006). 
Another important feature of the 
contrast loading is the homogeneity of the 
uptake, varying from homogeneous loading 
in epedymoma to heterogeneous in 
astrocytoma (Adam et al. 2010; Harrop et 
al. 2009; Manzano et al. 2008; Waldron and 
Cha 2006; Bowers and Weprin 2003; 
Hoshimaru 2001). Similar finding was also 
found in our series. Further, the rate of 
loading and unloading of the contrast 
sunstance may offer an idea about the 
tumor histology, e.g., slower load in 
astrocytoma than ependymoma(Adam et al. 
2010; Harrop et al. 2009; Manzano et al. 
2008; Waldron and Cha 2006; Bowers and 
Weprin 2003; Hoshimaru 2001). (See Table 
4) 
Although MRI examination remains the 
most valuable investigation in SC 
pathologies, the clinical and laboratory data 
may improve its value in the diagnosis of 
nonspecific pathologies, such as metastatic 
melanoma, lymphoma and sarcoidosis. 
However, it is clearly that in some cases, the 
final diagnosis can be only derived from the 
histological exam.   
For instance, in the case of 
intramedullary SC tumors, MRI cannot 
provide an accurate assessment of the 
infiltrative nature of these. The SC 
dilatation or abnormal MRI signal within 
the SC are not pathognomonic for 
intramedullary tumors. MRI signal change 
in some extramedullary spinal lesions, e.g., 
enteric cysts, is another example of the MRI 
limitation to distinguished from SC 
intramedullary masses. One solution for 
this limitation is the MRI acquisition on 
multiple planes. However, the differential 
diagnosis between intra- and 
extramedullary tumors can be difficult 
when intramedullary tumor is partially 
exofitic. Furthermore, SC enlargements are 
present in other pathologies, such as 
syringomyelia fluid, multiple sclerosis, 
vascular malformations and post-irradiation 
myelopathy. Therefore, these pathologies 
should be excluded.  
Differential diagnosis between 
hydrosyringomyelia and intramedullary 
tumors is difficult by using myelography of 
myelo-CT alone. In contrast, MRI 
diagnosis of intramedullary cavities filled 
with fluid, on the sagittal and axial images, 
is relatively a common clinical practice.  
Another MRI limitation is in the 
differential diagnosis between multiple 
sclerosis (MS) and intramedullary tumor. 
For example, a MS’ plaque in the acute 
stage is characterized by a focal 
intramedullary lesion on T2-weigthed 
images accompanied by an SC enlargement. 
Clinical context and signs of intracranial 
demyelination on T2 images (particularly 
an increased periventricular signal) 
significantly helps the diagnosis. Finally, the 
lack of the intramedullary contrast several 
weeks after the baseline MRI evaluation 
confirms the diagnosis of MS. 
Images of vascular structures could be 
sometimes misleading. Although it is 
relatively easy to diagnose an intramedullary 
hematoma, this does not exclude the 
possibility of an intratumoral hemorrhage. 
A longitudinal MRI evaluation will provide 
required information to avoid the failure of 
diagnosis. Specifically, a structure with a 
long vascular nidus, visualized on 
myelography and MRI (particularly in T2-
 
 
 
S.C. Craciunas et al          Intramedullary Tumors 
 
 
 
weighted images) suggests a spinal medullar 
angioma. Vascular structures may be more 
visible in hemangioblastoma, but this entity 
is characterized by a nidus loading intense 
contrast. Perimedular venous drainage of 
dural fistulas can be associated with 
extensive hyper-intense areas on T2, but 
with no significant increasing in spinal cord 
dimensions. Spinal arteriography is used to 
confirm the diagnosis.  
In post-radiation myelopathy, the focal 
loading after contrast administration may 
raise difficulties in interpretation. History 
of disease in the area where the radiation 
has been applied, the clinical course and the 
characteristic changes in bone matrix are 
useful diagnostic indices. Further, the 
decisive argument in favor of post-radiation 
myelopathy is the absence of SC 
enlargement, although a potential 
enlargement can occur in the acute phase 
followed by a regression. Furthermore, this 
regression might continue, and an atrophy 
of SC can be documented on subsequent 
MRI evaluations. 
Despite all our efforts, we still account a 
major problem, the distinction between 
astrocytoma and ependymoma. This 
distinction is critical for tumor resectability, 
such as subtotal resection or biopsy for 
astrocytoma and total resection for 
ependymoma. Astrocytoma, a long tumor 
with edges poorly demarcated, is frequently 
located at the thoracic level. These tumors 
are eccentric, show moderate and partial 
heterogeneous contrast enhancement, and 
can present intra-tumoralcysts. In contrast, 
ependymoma are usually less extensive and 
well-defined tumors localized particularly 
at the cervical level. These tumors show 
intense and homogeneous contrast 
enhancement, and are often presenting 
large cysts and cap sign.  
We need to mention the technical 
limitations of a MRI evaluation. For 
example, the artifacts related to CSF 
motion are one of the common limitations. 
Using effective techniques for flow 
compensation however eliminates this. 
Another example is the difficulty to achieve 
accurate spatial reconstruction in patients 
with severe spinal deformity. For this, a 
GE-3D sequences can provide a valuable 
volumetric image acquisition. Finally, the 
slice thickness must be reduced as much as 
possible (3mm or less) to avoid partial 
volume effects and the acquisition in 
different planes may help to precisely 
characterize the tumor. 
Conclusions 
In summary, by combining MRI 
features of intramedullary tumor with 
medical history and clinical examination the 
tumor histology could be predicted with a 
reasonable accuracy. This is important in 
neurosurgical practice, allowing an 
appropriate surgical management of these 
lesions and providing pertinent predictors 
of the functional outcome post-surgery. 
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